Serivisi zacu

Kuvura neza bitangirana no gusuzuma neza. Abahanga bacu b'indwara zandura bafata umwanya wo kubikemura.

Dutanga serivisi zuzuye zo gusuzuma, kugisha inama, no kuvura abafite indwara ziterwa n’ibinyabuzima cyangwa virusi, harimo virusi, bagiteri, ibihumyo, na parasite.

Ikipe yacu ifite ubumenyi bwinshi bwubwandu bworoshye kandi butandukanye, nka:

Hepatitis C (HCV) Program

• Program established in 2021
• Serving nearly 350 patients with chronic hepatitis C, 83% began treatment with 98% of those who started completing treatment

STI Testing and Treatment along with Preventative Services

• Pre-exposure prophylaxis to prevent HIV (PrEP) and other STIs including chlamydia, gonorrhea, and syphilis (doxy PEP)
• Post-exposure prophylaxis to prevent HIV after health care related exposures and non-health care related exposures

Treatment for Common and Complex Infections

• Management of recurrent UTIs, bone and soft tissue infections, gastrointestinal infections, pneumonias, sinusitis, fevers of unknown origin, and any other infection

Injectable Treatments

• Patient Reach: Nearly 50 patients on injectable medications.
• Common Injectable Medications: Apretude & Cabenuva

Mary Louise Decker, M.D., FIDSA, is a board-certified infectious disease physician and Infectious Disease Medical Director for The Wright Center for Community Health.